BIOLASE Reports Unaudited Revenue Growth for Full Year 2023 and Provides Outlook for Full Year 2024
Dentistry Today
JANUARY 29, 2024
The company believes it is well-positioned with its industry-leading dental lasers and broad intellectual property (“IP”) portfolio to capitalize on the significant market opportunity for dental laser adoption and, with the year-end cash and cash equivalents balance of $6.6
Let's personalize your content